Pulmonology

Your Article Summary

See Latest Articles

Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT
Clinical Imaging, 07/02/09

Ventura E et al. - Of 31 patients with lung cancer, 19 underwent PET-CT and 12 had CT followed by PET. Sensitivities, specificities, positive, and negative predictive values were calculated based on histopathology. Ninety nodes were identified. Sensitivity, specificity, PPV, and NPV were 94%, 73%, 66%, and 96% for PET-CT, respectively. In 12 patients who underwent PET and CT separately, these values were 90%, 31%, 64%, and 71% for PET and 81%, 50%, 69%, and 66% for CT, respectively.

Today in Diagnostic/Lung Function...keeping you current

Receive free subspecialty "5-minute updates" via email

Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine, 10/20/09

Severity Staging of Chronic Obstructive Pulmonary Disease: Differences in Pre- and Post-Bronchodilator Spirometry
Yonsei Medical Journal, 10/23/09

Pulmonary function testing in young children
Paediatric Respiratory Reviews, 11/04/09

See All of Diagnostic/Lung Function

Today in Lung/Thoracic Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09

Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
Annals of Oncology, 10/19/09

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09

See All of Lung/Thoracic Oncology